EN
HI
Lincoln Pharmaceuticals share price chart
Lincoln Pharmaceuticals Share Key Metrics
Volume
1.35 L
Market Cap
1228.62 CR
LTQ@LTP
120@613.40
ATP
626.82
Var Margin
21.09 %
Circuit Range
490.75-736.05
Delivery %
16.12 %
Value
8.45 CR
ASM/GSM
No
Market Lot
1
Summary
LINCOLN stock price is ₹613.4 as of 15 Aug, 2026. The stock intraday movement has stayed between ₹609.30 and ₹644.40, while Lincoln Pharmaceuticals share price 52 week high low is ₹440.00 & ₹770.00.
In terms of trading activity, LINCOLN share price has recorded a volume of 1,34,766 shares. The Lincoln Pharmaceuticals has a market cap of ₹20029728. The stock’s Average Traded Price (ATP) stands at ₹626.82, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 120 @ ₹613.40.
The Lincoln Pharmaceuticals upper circuit limit is ₹736.05 & The Lincoln Pharmaceuticals lower circuit limit is ₹490.75, with a Value of ₹8.45 CR. The Delivery Percentage for the day is 16.12%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Lincoln Pharmaceuticals Fundamentals
P/E Ratio
12.73
P/B Ratio
1.55
Div. Yield
0.29
Sector P/E
63.94
Sector P/B
3.33
Sec. Div. Yield
0.51
Lincoln Pharmaceuticals Resistance and Support
Pivot 619.47
Resistance
First Resistance
646.99
Second Resistance
674.47
Third Resistance
701.99
Support
First Support
591.99
Second Support
564.47
Third Support
536.99
Lincoln Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 14 2026 | 638 | 613.4 | -0.98% | 644.4 | 609.3 |
| Thu Aug 13 2026 | 597.09 | 619.5 | 4.50% | 646.95 | 591.95 |
| Wed Aug 12 2026 | 585 | 592.84 | -0.61% | 597.79 | 585 |
Lincoln Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-13 | Quarterly Results |
| 2026-05-28 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Lincoln Pharmaceuticals News
Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Outcome for Board Meeting Outcome For Un-Audited Financial Results For The Quarter Ended On June 30, 2026.
Lincoln Pharmaceuticals reported Q1 FY27 consolidated net profit of ₹36.23 cr, up 30.90% YoY, with total income increasing 19.02% to ₹201.55 cr. EBITDA also rose 32.29% to ₹51.70 cr for the quarter. The board recommended an 18% dividend (₹1.80/share) for FY26.
Aug 13 2026 11:37:25
Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.
Lincoln Pharmaceuticals will hold a board meeting on August 13, 2026. The primary agenda is to consider and approve the un-audited financial results for the first quarter of FY27.
Aug 06 2026 12:37:22
Lincoln Pharmaceuticals Management
| Name | Position |
|---|---|
| Trusha Shah | Company Secretary & Compliance Officer |
| Kishor M Shah | Chairman |
Lincoln Pharmaceuticals Similar Stocks
Amrutanjan Health Care Ltd.
496.05
4.45 (0.91%)
Fermenta Biotech Ltd.
450.05
-10.00 (2.17%)
GPT Healthcare Ltd.
156.15
1.17 (0.75%)
Q-Line Biotech Ltd.
532.80
1.95 (0.37%)
Bajaj Healthcare Ltd.
329.25
-2.10 (0.63%)
Laxmi Dental Ltd.
201.82
-4.41 (2.14%)
Unihealth Hospitals Ltd.
676.15
-26.55 (3.78%)
Gujarat Kidney And Super Speciality Ltd.
136.43
0.25 (0.18%)
Sigachi Industries Ltd.
0.00
0.00 (0.00%)
Lincoln Pharmaceuticals FAQs
The Buying Price of Lincoln Pharmaceuticals share is 613.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Lincoln Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Lincoln Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Lincoln Pharmaceuticals shares is 12.73. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Lincoln Pharmaceuticals shares is 1.55. Useful to assess the stock's value relative to its book value.
To assess Lincoln Pharmaceuticals’s valuation compare Sector P/E, P/B which are 63.94 & 3.33 with sector averages, along with growth rates and financial metrics.
The Market Cap of Lincoln Pharmaceuticals is 1228.62 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Lincoln Pharmaceuticals share price is 770.00 & 440.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Lincoln Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
